NCT06140199

Brief Summary

The goal of this randomized clinical trial is to establish the efficacy of 'pit picking with laser therapy' versus 'pit picking alone' on both short and long-term outcomes in patients of 12 years and older with primary pilonidal sinus disease. The main questions it aims to answer are:

  • The overall success rate of treatment which is defined as: closure of all pits at 12 months of follow-up.
  • Secondary endpoints: succes rat eof treatment during long-term follow-up, wound closure time, pain scores, complication rate, work rehabilitation, time to return to daily activities, quality of life, persisting complaints, patient satisfaction, costs and the need for secondary or revision surgery. Participants will allocated to pit picking alone or combined with lasertherapy. The extra burden for participating patients is expected to be minimal to moderate. Participants will have two extra hospital visits in casethey are enrolled in our study: 6 and 12 months after enrolment. Postoperatively the normal scheme of follow up appointments wil be used: 2 and 6 weeks after treatment at the outpatient clinic of the treating surgeon. A telephone appointment with the researcher will be scheduled 4 weeks after treatment. Patients are asked to complete questionnaires at various time points, which will be sentto them by email and will take approximately 5-10 minutes each time. The content includes general and disease specific Quality of Life (QoL) questionnaires. The investigators do not expect any extra adverse reactions or events in respect to participation in the study because both procedures are considered standard of care in the participating clinics. However, because both interventions are surgical procedures a small percentage of adverse events or postoperative complications can be expected.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
482

participants targeted

Target at P75+ for not_applicable

Timeline
72mo left

Started Aug 2024

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Aug 2024May 2032

First Submitted

Initial submission to the registry

November 14, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

August 28, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2032

Last Updated

August 29, 2024

Status Verified

August 1, 2024

Enrollment Period

2.7 years

First QC Date

November 14, 2023

Last Update Submit

August 28, 2024

Conditions

Keywords

Pit-pickingLaser-assisted therapySiLaCMinimally invasive surgery

Outcome Measures

Primary Outcomes (1)

  • Succes rate of treatment

    Success rate of treatment, defined as closure of all pits at 1 year follow-up. Closure of the pits will be assessed by the treating surgeon by means of an extensive physical examination.

    1 year

Secondary Outcomes (11)

  • Success rate of treatment at long-term follow-up

    3-5 years

  • Pain score

    6 weeks

  • Patient reported outcome measures

    5 years

  • Wound healing and complications

    1 year

  • Work rehabilation

    6 weeks

  • +6 more secondary outcomes

Study Arms (2)

Pit-picking surgery

ACTIVE COMPARATOR
Procedure: Pit-picking surgery

Pit-picking surgery with Sinus Laser assisted Closure

EXPERIMENTAL
Procedure: Pit-picking surgery with Sinus Laser assisted Closure

Interventions

Patients are placed in left-side position. After shaving, cleaning and scrubbing of the skin with alcoholic chlorhexidine, double strong tape is placed on the right buttock in order to increase exposure. Local anaesthesia is administered before incision with 20 ml xylocaine or lidocaine 1-2%. In principle, all sinusoidal pits are cut out with a margin of at least 1 mm with a biopsy core punch (4 mm, 6 mm or 8 mm depending on pit size) or an oval excision of the pits is performed. Hair and debris is removed from the sinus tracts with a small surgical spoon or mosquito clamp. Rigorous de-epithelialisation of the underlying sinus is performed with the spoon through every pit, whilst removing even more debris and hairs. At the end of the procedure a debris washout is performed with saline solution, the wounds are left open for secondary healing and sterile dressings are applied.

Pit-picking surgery

The pit picking procedure is described above. Subsequently, a radial diode laser probe at 1470 nm wavelength is used for delivering homogeneous (360 degrees) energy to the surrounding epithelium. The laser energy is 13 Joule, given continuously. First, a 'preparatory laser treatment' is performed to extract any missed hairs or debris, after which the sinus tracts are cleansed with a surgical spoon again. During the following definitive procedure, the probe is withdrawn at an approximate speed of 1 cm per three seconds, causing the small sinus tracts to shrink and close. Large sinus tracts remain open because very large sinus tracts or cavities cannot be closed with the 3mm laser fibre. The injury to the endothelium will cause granulation and create oedema for collapsing of the tract. The remaining open wounds are left open for secondary healing and sterile dressings are applied.

Pit-picking surgery with Sinus Laser assisted Closure

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All patients aged 12 years and older who present with primary pilonidal sinus disease; Type 1b and 3 of the Dutch staging system
  • Obtained written informed consent by the patient and/or legal representative/parent
  • Sufficient understanding of the Dutch written language (reading and writing)
  • Eligible for questionnaires sent by e-mail

You may not qualify if:

  • Asymptomatic (Type 1a), recurrent (Type 4; except those patients who only have had drainage of their abscess and no other surgical treatment), or chronic wounds (hypergranulating) after PSD surgery (Type 5) of the Dutch staging system
  • Patients with known underlying or concomitant medical conditions that may interfere with normal wound healing (e.g. systemic skin and connective tissue diseases, any kind of congenital defect of metabolism including insulin-dependent diabetes mellitus, Cushing syndrome or disease, scurvy, chronic hypothyroidism, congenital or acquired immunosuppressive condition, chronic renal failure, or chronic hepatic dysfunction (Child-Pugh class B or C), severe malnutrition, or other concomitant illness which, in the opinion of the investigator, has the potential to significantly delay wound healing)
  • Severe drug abuse (and therefore protocol deviation can be expected)
  • Patients expected not to comply with the study protocol (including patients with severe cognitive dysfunction/impairment and severe psychiatric disorders)
  • Patients with insufficient knowledge of the Dutch written language who are thus unable to answer the questionnaires
  • Patients that are unable or not willing to give full informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Sluckin TC, Hazen SJA, Smeenk RM, Schouten R. Sinus laser-assisted closure (SiLaC(R)) for pilonidal disease: results of a multicentre cohort study. Tech Coloproctol. 2022 Feb;26(2):135-141. doi: 10.1007/s10151-021-02550-4. Epub 2022 Jan 7.

MeSH Terms

Conditions

Pilonidal Sinus

Condition Hierarchy (Ancestors)

CystsNeoplasms

Study Officials

  • Robert Smeenk, MD PhD

    Albert Schweitzer Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Justin Youp van Oostendorp, MD MSc

CONTACT

Robert Smeenk, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Only the outcome assessor is blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Multicentre, single-blinded, randomised, controlled, superiority trial. It
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Local investigator

Study Record Dates

First Submitted

November 14, 2023

First Posted

November 18, 2023

Study Start

August 28, 2024

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2032

Last Updated

August 29, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

On reasonable request.